Kristen Detweiler‐Short

781 total citations
12 papers, 519 citations indexed

About

Kristen Detweiler‐Short is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kristen Detweiler‐Short has authored 12 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Kristen Detweiler‐Short's work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Protein Degradation and Inhibitors (4 papers). Kristen Detweiler‐Short is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Protein Degradation and Inhibitors (4 papers). Kristen Detweiler‐Short collaborates with scholars based in United States and Poland. Kristen Detweiler‐Short's co-authors include Tara Anderson, Daniel Lebovic, Kent A. Griffith, Andrzej Jakubowiak, Mark Kaminski, Ravi Vij, Daniel R. Couriel, Sundar Jagannath, Keith Stockerl‐Goldstein and Dominik Dytfeld and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Kristen Detweiler‐Short

12 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristen Detweiler‐Short United States	7	458	425	232	71	32	12	519
Cara A. Rosenbaum United States	13	331 0.7×	334 0.8×	214 0.9×	56 0.8×	8 0.3×	46	441
Siyang Leng United States	10	210 0.5×	100 0.2×	118 0.5×	81 1.1×	28 0.9×	31	325
Cesare Bergonzi Italy	9	175 0.4×	229 0.5×	124 0.5×	40 0.6×	11 0.3×	19	318
Miquel Granell Spain	10	163 0.4×	223 0.5×	156 0.7×	70 1.0×	33 1.0×	27	317
Ma Teresa Cibeira Spain	8	224 0.5×	272 0.6×	153 0.7×	51 0.7×	6 0.2×	13	306
E. Stadtmauer United States	8	184 0.4×	271 0.6×	168 0.7×	55 0.8×	4 0.1×	16	365
M Martín-Ayuso Spain	9	110 0.2×	164 0.4×	66 0.3×	54 0.8×	20 0.6×	10	280
Edvan de Queiroz Crusoé Brazil	8	233 0.5×	229 0.5×	156 0.7×	33 0.5×	9 0.3×	41	353
David C. de Leeuw Netherlands	9	160 0.3×	157 0.4×	46 0.2×	30 0.4×	21 0.7×	25	316
Yaozhong Zhao China	10	152 0.3×	219 0.5×	146 0.6×	57 0.8×	9 0.3×	20	314

Countries citing papers authored by Kristen Detweiler‐Short

Since Specialization

Citations

This map shows the geographic impact of Kristen Detweiler‐Short's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen Detweiler‐Short with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen Detweiler‐Short more than expected).

Fields of papers citing papers by Kristen Detweiler‐Short

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen Detweiler‐Short. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen Detweiler‐Short. The network helps show where Kristen Detweiler‐Short may publish in the future.

Co-authorship network of co-authors of Kristen Detweiler‐Short

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen Detweiler‐Short. A scholar is included among the top collaborators of Kristen Detweiler‐Short based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen Detweiler‐Short. Kristen Detweiler‐Short is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Jakubowiak, Andrzej, Dominik Dytfeld, Kent A. Griffith, et al.. (2013). Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up.. Journal of Clinical Oncology. 31(15_suppl). 8543–8543. 13 indexed citations

Jakubowiak, Andrzej, Dominik Dytfeld, Kent A. Griffith, et al.. (2012). A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma. Blood. 120(9). 1801–1809. 311 indexed citations

Lebovic, Daniel, Mark Kaminski, Tara Anderson, et al.. (2012). A Phase II Study of Consolidation Treatment with Iodione-131 Tositumomab (Bexxar™) in Multiple Myeloma (MM). Blood. 120(21). 1854–1854. 7 indexed citations

Jakubowiak, Andrzej, Dominik Dytfeld, Sundar Jagannath, et al.. (2011). Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM). Blood. 118(21). 631–631. 18 indexed citations

Madan, Sumit, Martha Q. Lacy, Angela Dispenzieri, et al.. (2011). Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma. Blood. 118(7). 1763–1765. 42 indexed citations

Dispenzieri, Angela, David Dingli, Shaji Kumar, et al.. (2010). Discordance between serum cardiac biomarker and immunoglobulin‐free light‐chain response in patients with immunoglobulin light‐chain amyloidosis treated with immune modulatory drugs. American Journal of Hematology. 85(10). 757–759. 93 indexed citations

Detweiler‐Short, Kristen, Suzanne R. Hayman, Morie A. Gertz, et al.. (2010). Long‐term results of single‐agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma. American Journal of Hematology. 85(10). 737–740. 15 indexed citations

Kumar, Shaji, Morie A. Gertz, Martha Q. Lacy, et al.. (2010). Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score. Blood. 116(21). 1892–1892. 6 indexed citations

Kumar, Shaji, Angela Dispenzieri, Martha Q. Lacy, et al.. (2010). Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function. Blood. 116(21). 2970–2970. 2 indexed citations

10.

Madan, Sumit, Martha Q. Lacy, Angela Dispenzieri, et al.. (2010). Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma. Blood. 116(21). 1964–1964. 5 indexed citations

11.

Dispenzieri, Angela, Morie A. Gertz, Suzanne R. Hayman, et al.. (2010). A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis. Blood. 116(21). 987–987. 5 indexed citations

12.

Witzig, Thomas E., Sumithra J. Mandrekar, Kristen Detweiler‐Short, et al.. (2010). A Phase III Randomized Trial of Thalidomide (THAL) Plus Zoledronic Acid (ZLD) Versus Zoledronic Acid Alone In Patients with Early Stage Multiple Myeloma (MC0289). Blood. 116(21). 3053–3053. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact